January 11, 2017 Nexstim Plc announces signing of an Independent Selling Representative Agreements in U.S.
January 09, 2017 Strongbridge Biopharma plc Expands Commercial Capabilities with Two Rare Disease Executive Hires
January 05, 2017 Aprea Therapeutics Announces Presentation at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco
December 23, 2016 Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro